SOURCE: Medivation

Medivation

November 29, 2012 17:00 ET

Medivation Announces Participation at Upcoming Investor Conferences

SAN FRANCISCO, CA--(Marketwire - Nov 29, 2012) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:

  • David Hung, M.D., president and chief executive officer, will present at the Deutsche Bank BioFEST Conference on December 3 at 9:35am Eastern Time in Boston, MA.
  • David Hung, M.D., president and chief executive officer, will present at the JP Morgan Healthcare Conference on January 7 at 4:30pm Pacific Time in San Francisco, CA.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contact Information

  • Contacts:
    Patrick Machado
    Chief Business & Financial Officer
    (415) 829-4101

    Anne Bowdidge
    Sr. Director
    Investor Relations
    (650) 218-6900